相关实验视频
Updated: Jul 16, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
在Shellharbour医院的DKA/HHS胰岛素输注协议的遵守和患者的结果
Amanda Khor1, Mohammad Mohiuddin1
1Department of Medicine, Shellharbour Hospital, Illawarra, New South Wales, Australia.
Internal medicine journal
|June 6, 2023
概括
这次对糖尿病酸性 (DKA) 和超小胞性高糖血症状态 (HHS) 管理的审计发现替代的改善,但流体管理和胰岛素过渡的缺陷,突出了加强患者护理的领域.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 糖尿病管理 糖尿病管理
背景情况:
- 糖尿病酸性脂肪酸 (DKA) 和高血糖症 (HHS) 是重要的医疗紧急情况.
- 及时评估和管理对于预防严重并发症至关重要.
研究的目的:
- 为了评估对DKA/HHS胰岛素输注协议的遵守.
- 评估患者的结果并与2016年的审计进行比较.
- 确定在DKA/HHS治疗中需要改进的领域.
主要方法:
- 在Shellharbour医院接受DKA或HHS的40名患者的审计.
- 在液体/替代,胰岛素/乳糖定时和胰岛素过渡中评估协议的遵守.
- 评估结果,包括住院,ICU转移和低血糖的发生率.
主要成果:
- 协议的遵守程度有所不同:补液 (40%),补 (72.5%),胰岛素计划 (82.5%),乳糖开始 (80%),皮下胰岛素过渡 (87.5%).
- 在62.5%的病例中,胰岛素输注和皮下胰岛素发生了适当的重叠.
- 与2016年相比,补充改善了,但液体补充减少了;低血糖症发生在3名患者中,管理不佳.
结论:
- DKA/HHS管理需要改进,特别是在液体和替代方面.
- 优化从胰岛素输注到皮下胰岛素的过渡至关重要.
- 需要进一步的审计来监测协议的遵守和患者的结果.
相关概念视频
SBAR II: Application of SBAR
4.5K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.5K
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Insulin Formulations: Types and Delivery
238
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
238
Insulin: Dosing Regimen and Adverse Effects
216
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
216
